health pharma news today obesity drugs glp-1 Drugmaker Eli Lilly announced that the FDA approved its daily pill, which will be marketed under the name Foundayo, to treat obesity. ABC News' Youri Benadjaoud reports. , Could weight-loss drugs eat the

'junior high school gal')

Natarajan V, Ganju P, Ramkumar A, et al

Most side effects can be managed by starting with a lower dose and gradually increasing as your body adjusts to the medication

Energy and Focus Boost Caffeine and L-tyrosine provide mental and physical stimulation, helping you stay energized and focused during workouts and throughout the day

Results obtained from randomized clinical trials, however, were inconsistent and in some circumstances have indicated that antioxidants increase cancer risk (Klein et al., 2011

Diabetes 68(Supplement 1):58-OR van Can J, Sloth B, Jensen CB, Flint A, Blaak EE, Saris WHM (2014) Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults